Inter Parfums Inc. (0IUJ)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 32.02 |
|---|---|
| 52-week range | 19.94 – 32.12 |
| Return, 1 month / 3 months | +10.7% / +21.4% |
| Return, 1 year / 3 years | +21.9% / −17.1% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 31.5% |
| Worst drawdown (1 year) | -27.9% |
| Average daily value traded | 0.24M EUR |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Inter Parfums is a fragrance company based in New York that creates, manufactures and distributes perfumes and related beauty products. It works under licence agreements with fashion and lifestyle brands, producing scents sold under those brand names. Its customers are retailers such as department stores, specialty shops and travel retail outlets, and its products reach consumers in many countries. The company also develops ancillary fragrance items and manages the design and marketing of the products it makes for its partner brands.
On this site Inter Parfums Inc. appears as a stock on the London Exchange (UK), code 0IUJ, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Inter Parfums Inc. (0IUJ) trades on the London Exchange in UK. It last closed at EUR 32.02 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 627 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.9% and over the last three months it rose 21.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.0% | ||
| From 52-week high | -0.1% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 21.4% | ||
| 6-month return | 45.1% | ||
| 12-month return, skipping the last month | 10.1% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.9% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.24M EUR | ||
| Zero-volume days | 11.7% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.2% |
|---|---|
| 1 month | +10.7% |
| 3 months | +21.4% |
| 6 months | +45.1% |
| 1 year | +21.9% |
| 3 years | −17.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 28.59 / 24.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.15 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | EUR 1.0500 |
| 28 Apr 2025 | EUR 1.1500 |
| 26 Apr 2024 | EUR 1.1500 |
| 11 May 2023 | EUR 1.0500 |
| 16 May 2022 | EUR 0.9400 |
| 3 May 2021 | EUR 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.